Over the last year, it has been discovered that Zantac and generic versions of the popular heartburn drug could lead to a higher risk of cancer for those who take the medications. Many pharmacies have previously pulled these medications off the shelf, but now the US Food and Drug Administration (FDA) has asked manufacturers to stop selling them. Many lawsuits have been filed against the makers of Zantac, and in these cases have been consolidated in order to streamline the process. At the SMA Law Group, our Pittsburgh Zantac cancer attorneys want to discuss what consolidation means for these cases.
What Does Consolidation of Zantac Cases Mean?
Many people have seen on the news that, as of April 1, 2020, the FDA has asked manufacturers of Zantac and all generic versions of ranitidine discontinue selling prescription and over-the-counter versions of the medications. The FDA has also asked any consumers who still have this medication in their homes to properly dispose of the product immediately.
Since independent laboratory testing discovered high levels of the cancer-causing carcinogen N-nitrosodimethylamine (NDMA) in dosages of Zantac and other ranitidine products, many lawsuits have been filed against Sanofi, the maker of Zantac. As is customary when there are many federal cases filed related to the same issue, the Judicial Panel on Multidistrict Litigation decided to consolidate all of these cases. They have all been moved to US District Judge Robin Rosenberg in Miami, Florida.
Multidistrict litigation is the procedure used when there are several civil cases related to the same topic. If each of these cases were tried separately, a successful resolution would take much longer and would be repetitive. Consolidating all these cases into one could result in quicker compensation and justice for those allegedly injured after taking Zantac and other ranitidine products.
Just because these cases have been consolidated does not mean that those injured after taking Zantac cannot file a lawsuit. In fact, many more lawsuits are expected now that the FDA has weighed in and ordered the removal of all ranitidine products from the shelves.
Did Sanofi and other makers of ranitidine products know about the potential cancer risks of their products? If so, why did they not take steps to warn consumers?
The SMA Law Group is here to help victims who have been diagnosed with cancer, and we are not afraid to stand up to major pharmaceutical companies.
Let Us Help You With Your Case
If you or somebody you love has been diagnosed with cancer after taking Zantac, contact an attorney as soon as possible. At the SMA Law Group, our product liability team will investigate your case and work to secure any compensation you may be entitled to. This could include:
- Coverage of all medical bills related to the case
- Lost income and benefits if you are unable to work
- Mental anguish damages
- Loss of enjoyment of life damages
- Possible punitive damages against the manufacturer of Zantac or the generics